Allogeneic Stem Cell Transplantation Clinical Trial
Official title:
Prospective Evaluation of Efficacy of CMV-specific T Cell Immunity (CMV-TCIP) Directed Letermovir Prophylaxis After Allogeneic Hematopoietic Cell Transplantation
This is a phase 2, prospective cohort clinical trial evaluating the utilization of CMV T Cell Immunity Panel (CMV-TCIP) assay to guide the duration of primary CMV prophylaxis in CMV-seropositive recipients of allogeneic stem cell transplant or recipients receiving a stem cell graft from a CMV serology positive donor.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05443854 -
Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)
|
Phase 3 | |
Terminated |
NCT01185223 -
Study Comparing Valganciclovir Versus Ganciclovir in Patients Following Allogeneic Stem Cell Transplantation
|
Phase 3 | |
Not yet recruiting |
NCT01212796 -
Allo After Allo Stem Cell Transplantation Following Relapse After Allogeneic Transplant in Haematological Malignancies: Retrospective Results of the GETH
|
N/A | |
Terminated |
NCT00737113 -
Recombinant Human Growth Hormone (RH-GH) For Accelerating Immune Reconstitution Post Unrelated Cord Blood Transplant
|
Phase 1 | |
Recruiting |
NCT06028828 -
Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation
|
Phase 2 | |
Not yet recruiting |
NCT03964922 -
Immunoevasive Tactics Employed by Myeloid Malignancy After Allogeneic Stem Cell Transplantation
|
N/A | |
Completed |
NCT03467074 -
Role of Interferon-λ and Vaccine Response
|
||
Completed |
NCT02273024 -
Exercise Prior to Allogeneic Hematologic Stem Cell Transplantation
|
N/A | |
Recruiting |
NCT06093334 -
Imaging of Chemotherapy-induced Morphological and Functional Lung Changes in Childhood ALL and HD
|
N/A | |
Recruiting |
NCT03286530 -
Ruxolitinib + Allogeneic Stem Cell Transplantation in AML
|
Phase 2 | |
Completed |
NCT01092026 -
Unrelated Umbilical Cord Blood Transplantation With Coinfusion of Mesenchymal Stem Cells
|
N/A | |
Recruiting |
NCT00883714 -
Exercise During the Allogeneic Stem Cell Transplantation
|
Phase 3 | |
Recruiting |
NCT01160952 -
Long-term Versus Short-term Sequential Therapy (Intravenous Itraconazole Followed by Oral Solution) of Itraconazole as Primary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation
|
Phase 2 | |
Completed |
NCT04628338 -
IFN-γ to Treat Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) That Has Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation
|
Early Phase 1 | |
Completed |
NCT06256341 -
HHV-6-specific T-cell Reconstitution Among Children and Adolescents After Allogeneic Stem.
|
||
Completed |
NCT05088941 -
Impact of COVID-19 Pandemic on Allogeneic Stem Cell Transplantation Organization : a French Experience
|
||
Recruiting |
NCT02533947 -
Cognition in Allogeneic Stem Cell Transplanted Patients and Sports
|
N/A | |
Completed |
NCT01560689 -
Inhaled BUDESONIDE/FORMOTEROL in Bronchiolitis Obliterans Following Stem Cell Transplantation
|
Phase 2 | |
Not yet recruiting |
NCT06297629 -
A Phase I/II Trial to Assess the Efficacy and Toxicity of ASTX727 (Oral Decitabine/Cedazuridine) for the Treatment of Hematological Neoplasms After Allogeneic Stem Cell Transplantation
|
Phase 2 | |
Completed |
NCT01929980 -
Bortezomib to Treat Significant Complication of HSCT
|
Phase 2 |